Followers | 59 |
Posts | 8530 |
Boards Moderated | 1 |
Alias Born | 05/17/2016 |
Wednesday, July 18, 2018 10:35:10 PM
In 2017 Platinum Tax Defenders reported $3.2 million in revenue; and adjusted EBITDA of $457,000. This merger provides Cardiff Lexington entry into the ever-growing tax resolution business.
Here is a definition of revenues compared to EBITDA: https://www.investopedia.com/ask/answers/101314/what-are-differences-between-gross-profit-and-ebitda.asp
Gross profit = Revenue - Cost of Goods Sold
Revenue is the total amount of income earned from sales in a period. Revenue is also be called net sales because discounts and deductions from returned merchandise may have been deducted. Revenue is considered the top line earnings number for a company since it's located at the top of the income statement.
EBITDA = Operating Income + Depreciation and Amortization
Operating income is a company's profit after subtracting operating expenses or the costs of running the daily business. Operating income helps investors separate out the earnings for the company's operating performance by excluding interest and taxes.
So even though Platinum Tax Defenders reported a 3.2 million in revenues they actually put in their pockets $475K after all bills were paid.
Who knows? LOL
My potential stock picks are all of my own potential stock picks based on my very own DD. Use my posts as informational DD only. Your interpretation of them is solely on you and your own stock trading is 100% on you and no one else but you. Thank You
Recent CDIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:50:17 PM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 11/29/2023 03:18:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/16/2023 09:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 07:06:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/25/2023 07:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:56:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 05:25:09 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/03/2023 08:51:51 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2023 09:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 08:04:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM